Correlation Between Entera Bio and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Entera Bio and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entera Bio and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entera Bio and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Entera Bio and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entera Bio with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entera Bio and Anebulo Pharmaceuticals.
Diversification Opportunities for Entera Bio and Anebulo Pharmaceuticals
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Entera and Anebulo is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Entera Bio and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Entera Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entera Bio are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Entera Bio i.e., Entera Bio and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Entera Bio and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Entera Bio is expected to generate 0.97 times more return on investment than Anebulo Pharmaceuticals. However, Entera Bio is 1.03 times less risky than Anebulo Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 245.00 in Entera Bio on November 9, 2024 and sell it today you would earn a total of 7.00 from holding Entera Bio or generate 2.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Entera Bio vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Entera Bio |
| Anebulo Pharmaceuticals |
Entera Bio and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Entera Bio and Anebulo Pharmaceuticals
The main advantage of trading using opposite Entera Bio and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entera Bio position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Entera Bio vs. NLS Pharmaceutics AG | Entera Bio vs. Alterity Therapeutics | Entera Bio vs. Immutep Ltd ADR |
| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |